Re: you won’t see anyone buying this
in response to
by
posted on
Dec 11, 2023 01:36PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
What I see now is "weak & fragile" the same thing I see in this ceo - it's a direct reflection imo.